Mendelspod Podcast

Guest: Mike Snyder, Director, Center for Genomics & Personalized Medicine, Stanford Bio and Contact Info Listen (5:44) Current method for figuring out transcriptomes is crazy

Guest: Eliot Forster, Executive Chair, MedCity Bio and Contact Info Listen (2:54) Cashing in on illustrious life science tradition Listen (2:56) Culture of collaboration strong in the UK

Guest: David Haussler, Director, Center for Biomolecular Science and Engineering, UCSCBio and Contact Info Listen (8:08) Paperwork not algorithms the biggest challenge with bioinformatics

Guest: Pearl Huang, VP, Global Head of DPAc, GSK Bio and Contact Info Listen (6:28) What is the Discovery Fast Track Challenge? Listen (4:25) How do the reseachers benefit if they are chosen?

Guest: George Poste, Chief Scientist, Complex Adaptive Systems; Regents’ Professor and Del E. Webb Chair in Health Innovation, ASUBio and Contact Info Listen (5:51) A paradigm shift to systems thinking

Guest: Colleen Cutcliffe, CEO, Whole BiomeBio and Contact Info Listen (2:32) Do we know enough about the microbiome yet to commercialize it? Listen (5:58) The Complete Biome Test

Guests: Liz Mansfield, Deputy Office Director of Personalized Medicine, OIR, FDABio and Contact Info Katie Serrano, Deputy Director of the Division of Chemistry and Toxicology, OIR, FDABio and Contact Info Listen (4:08) What was submitted to Congress?

Guest: Steve Blank, Author, Entrepreneur, Educator Bio and Contact Info Chapters: (Advance the marker) Intro 0:59 What are you up to with the NIH? 4:39 The scientific method for entrepreneurship 8:14 Do scientists resist learning about business? 10:50 "I’m from the U.S. Government, and we need your help!"

Guest: Brett Ryan Bonowicz, FilmmakerBio and Contact Info Listen (4:00) Where is the "fiction" in your science fiction? Listen (4:47) Upcoming screenings

Guest: Don Berry, Prof of Statistics, MD Anderson Cancer CenterBio and Contact Info Listen (5:39) What is the goal of I-SPY trials? Listen (8:31) Why were adaptive trials not introduced sooner?

Guest: Pete Kissinger, Chemist, Purdue UniversityBio and Contact Info Listen (4:43) Many problems in life science traced back to poor measurements Listen (2:50) Innovation without quality

Guest: Brian Frezza, Co-Founder, Co-CEO, Emerald Therapeutics Bio and Contact Info Chapters: (Advance the marker) 0:50 What is the Emerald Cloud Lab? 4:16 Does this impact the scientific method? 10:00 Pulling the labor, not the scientist out 14:20 Much more data detail 19:52 A chance to improve reproducibility

Guest: Carolyn Compton, Professor of Pathology, ASUBio and Contact Info Listen (5:40) Quality of biomarker data limited by quality of biospecimen Listen (5:24) Degradation of samples

Guest: Liz Horn, PhD, Patient Advocate Bio and Contact Info Listen (8:22) What is biobanking? Listen (4:05) Sample collection and the diagnostic odyssey

Guest: Misha Angrist, Author, Assoc. Professor, Duke Institute for Genomic Sciences Bio and Contact Info Listen (7:03) Presidential bioethics commissions do not have a good record

Guest: Misha Angrist, Author, Assoc. Professor, Duke Institute for Genomic Sciences Bio and Contact Info Listen (7:25) New MA in Bioethics and Science Policy

Guest: Liran Shlush, Researcher, Princess Margaret Cancer Center Bio and Contact Info Listen (4:44) Preleukemic stem cells Listen (7:42) Implications for AML therapy and diagnosis

Guest: Russ Altman, Dept Chair, Bioengineering, Stanford University Bio and Contact Info Listen (5:32) A bioinformatician bottleneck? Listen (4:19) Does the engineer or coder have enough basic biology?

Guests: Larry Goldstein, PhD, Director, UCSD Stem Cell Program Bio and Contact Info Listen (3:16) Where are we at today with stem cell research? Listen (5:14) One step beyond animal models

Guest: Colleen Campbell, Assistant Director, University of Iowa - Iowa Institute for Human Genetics Bio and Contact Info Listen (2:35) How are you implementing genomic medicine?